Ankita Srivastava is the Head of Pharmacovigilance at ProKidney with over 15 years of experience in global drug safety, medical oversight, and regulatory strategy. A clinician (dentist) by training with a regulatory affairs certification from Duke University School of Medicine, she brings a balanced clinical and regulatory perspective to safety leadership.
Previously, Ankita led Pharmacovigilance and Medical Monitoring at Vistagen Therapeutics and Arvinas , where she built core safety functions and supported a successful NDA submission. She is also an active member of Women In Bio and is passionate about mentorship and advancing patient‑centered pharmacovigilance practices.